The goal of this observational study is to evaluate the Thoraflex Hybrid device alone and in combination with the RelayPro NBS stent-graft in the treatment of aortic disease affecting the aortic arch and descending aorta with or without involvement of the ascending aorta. Patients who undergo treatment with the Thoraflex Hybrid device with or without extension with a RelayPro NBS stent-graft will be eligible for enrolment and study activities and follow-up regime will follow standard care at each participating site. Participant involvement in the study will last for a total of 10 years from the point at which the Thoraflex Hybrid device is placed.
Thoracic Diseases, Aortic Aneurysm, Aortic Dissection, Thoracic Aortic Aneurysm, Thoracic Aortic Dissection
The goal of this observational study is to evaluate the Thoraflex Hybrid device alone and in combination with the RelayPro NBS stent-graft in the treatment of aortic disease affecting the aortic arch and descending aorta with or without involvement of the ascending aorta. Patients who undergo treatment with the Thoraflex Hybrid device with or without extension with a RelayPro NBS stent-graft will be eligible for enrolment and study activities and follow-up regime will follow standard care at each participating site. Participant involvement in the study will last for a total of 10 years from the point at which the Thoraflex Hybrid device is placed.
Thoraflex Hybrid and Relay Extension Post-Approval Study
-
University of Alabama in Birmingham Medical Center, Birmingham, Alabama, United States, 35294
Cedars-Sinai Medical Centre, Los Angeles, California, United States, 90048
Keck Medical Centre of USC, Los Angeles, California, United States, 90089
University of Colorado, Aurora, Colorado, United States, 80045
Hartford Hospital, Hartford, Connecticut, United States, 06106
Medstar Washington Hospital Centre, Washington, District of Columbia, United States, 20010
Northwestern University, Chicago, Illinois, United States, 60611
Massachusetts General Hospital, Boston, Massachusetts, United States, 02114
Washington University/Barnes Jewish Hospital, Saint Louis, Missouri, United States, 63110
Weill Cornell medicine, New York, New York, United States, 10065
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Vascutek Ltd.,
Martin Czerny, PRINCIPAL_INVESTIGATOR, University of Freiburg
Joseph E Bavaria, PRINCIPAL_INVESTIGATOR, Jefferson Health and Sidney Kimmel Medical College
2036-12